Viewing StudyNCT05338892



Ignite Creation Date: 2024-05-06 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 2:30 PM
Study NCT ID: NCT05338892
Status: COMPLETED
Last Update Posted: 2023-10-19
First Post: 2022-04-14

Brief Title: Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for RelapsedRefractory Diffuse Large B-Cell Lymphoma
Sponsor: Regeneron Pharmaceuticals
Organization: Regeneron Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Diffuse Large B-Cell Lymphoma
Keywords:
Name View
ORCHID View
RelapsedRefractory Diffuse Large B-Cell Lymphoma rr DLBCL View
Non-Hodgkin lymphoma View
Chronic lymphocytic leukemia View
Follicular lymphoma View
Odronextamab View